Proteasome Cap Targeting Chimeras (CAP-TACs) are a class of small-molecule-based bifunctional recruiting molecules. These molecules are capable of recruiting a diverse range of target proteins (POIs)—including BRD4, PRMT5, and FKBP12—to specific subunits within the 19S regulatory cap region (e.g., the RPN13 or RPN1 subunits). This recruitment subsequently induces the degradation of these POIs via a mechanism that is proteasome-dependent but ubiquitin-independent.
RAFKBP12 是一种 FKBP12 CAP-TAC(蛋白酶体帽靶向嵌合体)降解剂,证明了 CAP-TAC 策略的可行性,即诱导不依赖于 E3 泛素连接酶和蛋白质泛素化、依赖蛋白酶体的 FKBP12 降解(粉色:FKBP12 配体 (MS-L77657);蓝色:Proteasome 配体 (MS-L83098);黑色:连接子)。
RAJQ14 是一种 BRD4 类 PROTAC CAP-TAC(蛋白酶体帽靶向嵌合体)降解剂,可结合 19S 蛋白酶体帽亚基 RPN1、RPN10、RPN13 和 USP14,将靶蛋白募集至蛋白酶体,以实现不依赖泛素化但依赖蛋白酶体的降解,可用于癌症研究(粉色:BRD4 配体 (MS-J72522);蓝色:蛋白酶体配体 (MS-D07130);黑色:连接子)。
© 2026 MolStrong. 保留所有权利。粤ICP备2023004355号
可通过CAS号进行批量搜索,一行一个CAS号